FundamentalVR raises $20m for surgical simulation

The medical simulation platform combines virtual reality and haptics through data, artificial intelligence and multimodal learning. FundamentalVR’s patented HapticVR technology mimics the physical touch of surgical actions, allowing users to experience the sights, sounds and physical sensations of real-life surgery.

Designed to be hardware-agnostic, the platform immerses users in a controlled training environment that lowers surgical risk to patients. It is deployed in over 30 countries and has replaced the need for surgeons to train on cadavers and wet labs, reducing costs and improving patient outcomes. 

The transaction was led by EQT Life Sciences investing from the LSP Health Economics Fund 2 and joined by prior investors Downing Ventures. The latest investments follow a Series A round in October 2019 and bring the company’s total funding to over $30m.

FundamentalVR’s high-fidelity simulations help life science, pharmaceutical and med-device companies deploy medical innovations in disciplines from ophthalmology to robotics, gene therapy and more. The growth investment will enable further development of HapticVR, the machine learning data insights product, and geographic expansion throughout the US.